Inspiratory Muscle Training in Pulmonary Hypertension

Inspiratory Muscle Training Effect on the Functional Capacity and the Quality of Life in Chronic Pulmonary Hypertension

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01410279

Enrollment

Registered

2011-08-05

Start date

2009-12-31

Completion date

2011-12-31

Last updated

2011-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Hypertension

Keywords

pulmonary hypertension, inspiratory muscle training, inspiratory muscle weakness, pulmonary functional, functional capacity, quality of life

Brief summary

The purpose of this study is evaluate the effect the inspiratory muscle training on the functional capacity of patients with pulmonary hypertension.

Detailed description

Pulmonary hypertension (PH) is a syndrome, in the case of hemodynamic alteration of a number of diseases and processes, such as the progressive increase in pulmonary vascular resistance, right heart failure and early death. Frequently patients with PH have reduced functional capacity, quality of life and survival. It was demonstrated recently that patients with HP also have inspiratory muscle weakness, possibly further increase the fatigue and dyspnea during exercise. To meet this need, inspiratory muscle training can lead to significant improvement in respiratory muscle strength, exercise tolerance and dyspnea, thus resulting in reduction of discomfort during activities of daily living, increase in exercise capacity and improved quality of life in different situations.

Interventions

OTHERInspiratory muscle training

The load is adjusted weekly in thirty percent of maximal inspiratory pressure of the subject.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to 75 Years

Healthy volunteers

Inclusion criteria

* Clinical diagnosis pulmonary hypertension * World Health Organization (WHO) functional class II to IV * inspiratory muscle weakness

Exclusion criteria

* obesity * chronic obstructive pulmonary disease * orthopedic and neurological disease

Design outcomes

Primary

Measure	Time frame
The distance traveled in meters in the six minutes walk test after 8 weeks the inspiratory muscle training	patients will be monitored throughout the training protocol for 8 weeks

Secondary

Measure	Time frame
Increase in score of quality of life questionnaire after 8 weeks the inspiratory muscle training	patients will be monitored throughout the training protocol for 8 weeks

Countries

Brazil

Contacts

Primary ContactPedro Dal'Lago

pdallago@ufcspa.edu.br55(51)3303-8796

Backup ContactGlória M Ferreira

glomenz@yahoo.com.br55(51)9284.0703

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026